CLONIDINE HYDROCHLORIDE (clonidine) by Gen Pharmaceuticals is mechanism of action epidurally administered clonidine produces dose-dependent analgesia not antagonized by opiate antagonists. Approved for combination with opiates for the treatment of severe pain in cancer patients. First approved in 2013.
Drug data last refreshed 21h ago
Mechanism of Action Epidurally administered clonidine produces dose-dependent analgesia not antagonized by opiate antagonists. The analgesia is limited to the body regions innervated by the spinal segments where analgesic concentrations of clonidine are present. Clonidine is thought to produce…
Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer.
Clonidine for Analgesia to Preterm Infants During Neonatal Intensive Care
Fentanyl and Clonidine for Analgesia During Hypothermia in Term Asphyxiated Infants
Efficacy, Safety and Pharmacokinetic Study of Intravenous Clonidine Versus Midazolam for Sedation in Paediatric Patients
Phase 1 PK, Bioavailability, Safety Study of Clonidine MBT w Catapres in Healthy Volunteers
Worked on CLONIDINE HYDROCHLORIDE at Gen Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo